Robert E. Funck Jr. - Feb 28, 2023 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role: EXECUTIVE VICE PRESIDENT
Signature: /s/ Robert E. Funck, Jr. by Jessica H. Paik, Attorney-in-Fact
Stock symbol: ABT
Transactions as of: Feb 28, 2023
Transactions value $: -$1,274,640
Form type: 4
Date filed: 3/2/2023, 06:35 PM
Previous filing: Feb 22, 2023
Next filing: Sep 15, 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ABT	Common shares without par value	Tax liability	-$1.15M	-11.5K	-4.98%	$99.77	220K	Feb 28, 2023	Direct
transaction	ABT	Common shares without par value	Sale	-$127K	-1.26K	-0.58%	$100.70	218K	Mar 1, 2023	Direct
holding	ABT	Common shares without par value						10K	Feb 28, 2023	By Trust	F1
holding	ABT	Common shares without par value						10K	Feb 28, 2023	By Trust	F1
holding	ABT	Common shares without par value						18.4K	Feb 28, 2023	Profit Sharing Trust	F2
holding	ABT	Common shares without par value						500	Feb 28, 2023	By Daughter	F3

Showing 1 to 6 of 6 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Held in daughter's annual gift trust. The reporting person disclaims beneficial ownership of all securities held by the trust.
F2	Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2023.
F3	The reporting person disclaims beneficial ownership of all securities held by his daughter.

Remarks:

The sale transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1(c).